STOCK TITAN

ORPEA Announces the First Drawdown of 250 Million Euros Under the Financing Agreement With Its Core Banking Pool

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

ORPEA has completed the necessary conditions for its financing agreements and has drawn down €250 million following the protocol announced on June 13, 2022. The drawn funds will be utilized for various corporate purposes, including debt service and capital expenditures. The company continues to execute the financing agreement as planned and will keep the market informed about the next steps in compliance with regulatory obligations. ORPEA is a leader in dependency care and is listed on Euronext Paris.

Positive
  • Successfully drew down €250 million to support corporate financing needs.
  • Continues with planned execution of financing agreements.
Negative
  • None.

PUTEAUX, France--(BUSINESS WIRE)-- Regulatory News:

Following the completion of the conditions precedent provided for in the financing agreements and the conciliation protocol announced on 13 June 2022, ORPEA (Paris:ORP) has just made a first drawdown of 250,000,000 euros. ORPEA also notes that the core banking pool who have provided the financing benefit from the security interests detailed in our Press Release published 13 June 2022.

The drawn funds will be used to finance and refinance general corporate purposes of the Group (including, but not limited to, debt service and capital expenditures) as well as the fees owed under the Financing Agreement.

The Company is therefore continuing with the execution of the financing agreement as envisaged and will continue to inform the market on the next steps of its implementation, in compliance with its legal and regulatory obligations.

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, post-acute and rehabilitation hospitals, mental health hospitals, home care services)

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Investor Relations

ORPEA

Benoit Lesieur

Investor Relations Director

b.lesieur@orpea.net

Investor Relations

NewCap

Dusan Oresansky

Tel. : +331 44 71 94 94

ORPEA@newcap.eu

Media Relations

Image 7

Charlotte Le Barbier

Tel.: +33 (0)6 78 37 27 60

clebarbier@image7.fr



Caroline Simon

Tel. : 06 89 87 61 24

Caroline.simon@image7.fr

Source: ORPEA

FAQ

What is the significance of ORPEA's €250 million drawdown?

The €250 million drawdown is intended to finance general corporate purposes, including debt servicing and capital expenditures.

When was the financing agreement protocol announced for ORPEA?

The financing agreement protocol was announced on June 13, 2022.

What will ORPEA use the drawn funds for?

The drawn funds will be used for general corporate purposes, debt service, and capital expenditures.

Is ORPEA continuing to implement its financing agreements?

Yes, ORPEA is proceeding with the execution of its financing agreements as planned.

Where is ORPEA listed?

ORPEA is listed on Euronext Paris.

Orpea SA

OTC:ORRRY

ORRRY Rankings

ORRRY Latest News

ORRRY Stock Data

371.54M
42.42k
Medical Care Facilities
Healthcare
Link
France
Puteaux